argus

Jagsonpal Pharmaceuticals Limited

NSE: JAGSNPHARMINE048B010351,577 Cr

Timeline

Time (IST)TypeMEventSrc
18 May, 05:52 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Resignation of Directorbse
06 May, 08:25 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Buyback Letter of Offernse
06 May, 08:23 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Submission Of Letter Of Offer For Buy-Back Upto 16,00,000 Equity Shares'.nse
04 May, 04:52 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
04 May, 04:48 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Transcriptnse
29 Apr, 04:47 pmSubmission of Public Announcement pertaining to Buyback of shares of the Company published in newspapers along with Board and Shareholder resolution.nse
28 Apr, 06:13 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
28 Apr, 06:11 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
27 Apr, 09:27 pmJagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board approves Dividendbse
27 Apr, 08:28 pmJagsonpal Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Buyback is 04-May-2026.nse
27 Apr, 08:27 pmJagsonpal Pharmaceuticals Ltd - 507789 - Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 16,00,000 Fully Paid-Up Equity Shares Of Face Value ?2/- Each At A Price Of ?250/- Per Share, For An Aggregate Amount Not Exceeding ?40 Croresbse
27 Apr, 08:18 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Grant of 1,93,000 ESOP'.nse
27 Apr, 08:05 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Dividend Updatense
27 Apr, 07:54 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Press Release for Audited Financial Results for quarter and year ended March 31, 2026".nse
27 Apr, 07:52 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
27 Apr, 07:52 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Presentationnse
27 Apr, 07:49 pmJagsonpal Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on April 27, 2026, recommended Final Dividend of Rs. 4 per equity share.nse
27 Apr, 07:46 pmJagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
27 Apr, 07:43 pmJagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action-Board to consider Dividendbse
27 Apr, 07:38 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
27 Apr, 07:19 pmJagsonpal Pharmaceuticals Ltd - 507789 - Audited Financial Results For The Year Ended March 31, 2026bse
27 Apr, 07:12 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meetingbse
27 Apr, 07:44 amJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 27, 2026, titled "Press Release on approval of Buy- Back of Equity shares of the Company.".nse
27 Apr, 07:41 amJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
20 Apr, 05:07 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Prior Intimation Of Board Meetingbse
13 Apr, 04:37 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 1,76,900 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.nse
25 Mar, 04:59 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about regarding notice of Postal Ballot relating to Approval for buy-back of up to 16,00,000 fully paid-up equity shares of face value ₹2/- each at a price of ₹250/- per share, for an aggregate amount not exceeding ₹40 crores.nse
13 Mar, 08:25 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
13 Mar, 08:14 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement Under Regulation 30 Of Sebi LODRbse
12 Mar, 02:32 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 12, 2026, titled "Press Release on announcement of Buy- Back of Equity shares of the Company".nse
12 Mar, 02:30 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
12 Mar, 02:03 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Buybacknse
12 Mar, 02:02 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 12, 2026.nse
09 Mar, 08:34 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The Companybse
09 Mar, 03:56 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement Under Regulation 30 Of SEBI LODRbse
09 Mar, 03:50 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 71800 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.nse
09 Mar, 03:45 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Intimation for grant of Employee Stock Options '.nse
27 Jan, 03:16 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Transcriptnse
27 Jan, 03:12 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
22 Jan, 07:04 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
22 Jan, 06:55 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
22 Jan, 09:50 amPursuant to the provisions of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of advertisement published on January 22, 2026, in Business Standard (English) and Business Standard (Hindi) newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025.We request you to take the above on record.nse
21 Jan, 07:14 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
21 Jan, 07:12 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
21 Jan, 07:10 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Investor Presentationnse
21 Jan, 07:09 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 21, 2026, titled "Press Release".nse
21 Jan, 07:07 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Presentationnse
21 Jan, 05:33 pmJagsonpal Pharmaceuticals Ltd - 507789 - Outcome Of Board Meeting Held On January 21, 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025bse
21 Jan, 05:10 pmJagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
21 Jan, 05:08 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting Held On January 21, 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025bse